# Efficacy of Spironolactone in Cameroonian Diabetic Patients With Resistant Hypertension

> **NCT02426099** · PHASE4 · COMPLETED · sponsor: **Sobngwi Eugene** · enrollment: 17 (actual)

## Conditions studied

- Hypertension, Resistant to Conventional Therapy
- Diabetes Mellitus

## Interventions

- **DRUG:** Low dose spironolactone
- **OTHER:** Routine intensification of antihypertensive treatment

## Key facts

- **NCT ID:** NCT02426099
- **Lead sponsor:** Sobngwi Eugene
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2015-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02426099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02426099, "Efficacy of Spironolactone in Cameroonian Diabetic Patients With Resistant Hypertension". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02426099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*